Biobanking Market by Expected Reach from $68,084 Million, by Leading & Growing at a CAGR of 4.6% from 2017 to 2025
Increase in incidence of chronic disease such as cancer bolsters the market of biobanking. Since the use of conventional therapies have serious side-effects, integrating it with stem cell therapy reduces the damage and hence the increased demand.
View full press release